Clinical Trial Update: Safety of Zileuton (Zyflo) in Combination With Imatinib Mesylate (Gleevec) in CML. [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the safety of combining zileuton (Zyflo) with imatinib mesylate (Gleevec) in chronic myeloid leukemia; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• ZYFLO (ZILEUTON)

Snippet

Sponsor: University of Massachusetts, Worcester | Conditions: Chronic Myelogenous Leukemia | Phase 1 | Status: TERMINATED